Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janice Wong

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Annals of the Academy of Medicine, Singapore|March 18, 2021
Causes, functional outcomes and healthcare utilisation of people with cerebral palsy in SingaporeZhi Min Ng, Jeremy B Lin, Poh Choo Khoo, et al.
Journal of Neurology|March 25, 2026
Long-term safety and efficacy of ponesimod in participants with relapsing multiple sclerosis: results from the phase 3 OPTIMUM 5-year long term extension studyXavier Montalban, Reinhard Hohlfeld, Carlo Pozzilli, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 20, 2025
Prevalence and risk factors of cerebral microhemorrhages and superficial siderosis in cognitively unimpaired older adults: analysis from the CHARIOT-PRO SubStudySujin Kang, Dimitra Kafetsouli, Jamie Ford, et al.
The Lancet. Child & Adolescent Health|June 5, 2021
Treatment of infantile-onset spinal muscular atrophy with nusinersen: final report of a phase 2, open-label, multicentre, dose-escalation studyRichard S Finkel, Claudia A Chiriboga, Jiri Vajsar, et al.
Arthritis and Rheumatism|October 2, 2007
The effects of vigorous exercise training on physical function in children with arthritis: a randomized, controlled, single-blinded trialDavinder Singh-Grewal, Jane Schneiderman-Walker, Virginia Wright, et al.
Gynecologic Oncology Reports|January 10, 2022
Standardization of caregiver and nursing perioperative care on gynecologic oncology wards in a resource-limited settingJanice Wong, Pius Mulamira, Jessica Arizu, et al.
Targeted Oncology|January 5, 2021
Results and Clinical Utilization of Foundation Medicine Molecular Tumor Profiling in Uterine and Ovarian CancersCatherine H Watson, Gloria Broadwater, Janice Wong, et al.
Radiology. Cardiothoracic Imaging|March 29, 2021
Prognosis of CT-derived Fractional Flow Reserve in the Prediction of Clinical OutcomesCharis G McNabney, Stephanie L Sellers, Ryan J A Wilson, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 29, 2022
Correction to: Design of a Randomized, Placebo-Controlled, Phase 3 Trial of Tofersen Initiated in Clinically Presymptomatic SOD1 Variant Carriers: the ATLAS StudyMichael Benatar, Joanne Wuu, Peter M Andersen, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|May 18, 2022
Design of a Randomized, Placebo-Controlled, Phase 3 Trial of Tofersen Initiated in Clinically Presymptomatic SOD1 Variant Carriers: the ATLAS StudyMichael Benatar, Joanne Wuu, Peter M Andersen, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Annals of the Academy of Medicine, Singapore|March 18, 2021
Causes, functional outcomes and healthcare utilisation of people with cerebral palsy in SingaporeZhi Min Ng, Jeremy B Lin, Poh Choo Khoo, et al.
Journal of Neurology|March 25, 2026
Long-term safety and efficacy of ponesimod in participants with relapsing multiple sclerosis: results from the phase 3 OPTIMUM 5-year long term extension studyXavier Montalban, Reinhard Hohlfeld, Carlo Pozzilli, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 20, 2025
Prevalence and risk factors of cerebral microhemorrhages and superficial siderosis in cognitively unimpaired older adults: analysis from the CHARIOT-PRO SubStudySujin Kang, Dimitra Kafetsouli, Jamie Ford, et al.
The Lancet. Child & Adolescent Health|June 5, 2021
Treatment of infantile-onset spinal muscular atrophy with nusinersen: final report of a phase 2, open-label, multicentre, dose-escalation studyRichard S Finkel, Claudia A Chiriboga, Jiri Vajsar, et al.
Arthritis and Rheumatism|October 2, 2007
The effects of vigorous exercise training on physical function in children with arthritis: a randomized, controlled, single-blinded trialDavinder Singh-Grewal, Jane Schneiderman-Walker, Virginia Wright, et al.
Gynecologic Oncology Reports|January 10, 2022
Standardization of caregiver and nursing perioperative care on gynecologic oncology wards in a resource-limited settingJanice Wong, Pius Mulamira, Jessica Arizu, et al.
Targeted Oncology|January 5, 2021
Results and Clinical Utilization of Foundation Medicine Molecular Tumor Profiling in Uterine and Ovarian CancersCatherine H Watson, Gloria Broadwater, Janice Wong, et al.
Radiology. Cardiothoracic Imaging|March 29, 2021
Prognosis of CT-derived Fractional Flow Reserve in the Prediction of Clinical OutcomesCharis G McNabney, Stephanie L Sellers, Ryan J A Wilson, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 29, 2022
Correction to: Design of a Randomized, Placebo-Controlled, Phase 3 Trial of Tofersen Initiated in Clinically Presymptomatic SOD1 Variant Carriers: the ATLAS StudyMichael Benatar, Joanne Wuu, Peter M Andersen, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|May 18, 2022
Design of a Randomized, Placebo-Controlled, Phase 3 Trial of Tofersen Initiated in Clinically Presymptomatic SOD1 Variant Carriers: the ATLAS StudyMichael Benatar, Joanne Wuu, Peter M Andersen, et al.
Pageof 6